Publication

Article

CURE

Summer 2007
Volume6
Issue 4

Medicare Coverage for Colon Cancer Screenings

What does Medicare cover when it comes to screening for colorectal cancer?

>

Benefits for individuals of average risk, age 50 or older:Fecal occult blood test (FOBT), every 12 months

>

Flexible sigmoidoscopy, every 48 months

>

Screening colonoscopy, every 10 years (no minimum age)

>

Barium enema, an alternative to flexible sigmoidoscopy or colonoscopy if your physician determines its screening value is equal or better

>

Benefits for high-risk* individuals, regardless of age: FOBT, every 12 months

>

Sigmoidoscopy, every 48 months

>

Colonoscopy, every 24 months

>

Barium enema, every 24 months

>

What you’ll pay: FOBT, completely covered by Medicare

>

Flexible sigmoidoscopy, colonoscopy or barium enema, 20 percent of Medicare-approved amount after yearly Part B deductible if done in a doctor’s office (and 25 percent for a flexible sigmoidoscopy or colonoscopy done in a hospital outpatient department)

>

*You’re high risk if you have:previously had colorectal cancer

>

a close relative with colorectal polyps or cancer

>

a history of polyps

>

inflammatory bowel disease

For information about Medicare coverage of cancer screenings and about risk factors, visit www.medicare.gov/Health/cancer.asp. To learn about the Welcome to Medicare visit, see www.medicare.gov/health/physicalexam.asp.

Newsletter

Stay up to date on cancer updates, research and education

Related Videos
Enhertu with Perjeta nearly doubled progression-free survival versus standard treatment in metastatic HER2-positive breast cancer, study shows.
Dr. Massimo Cristofanilli discusses the early use of camizestrant with a CDK4/6 inhibitor to target ESR1 mutations, as it may improve outcomes in metastatic breast cancer.
Image of woman.
Image of Dr. Eng.
Picture of Dr. Pouneh Razavi
Image of a woman wearing a headband and glasses
Image of doctor.
Image of woman.
Image of Doctor.